Teratogenic effects of antiepileptic drugs

Torbjörn Tomson, Dina Battino

Research output: Contribution to journalArticlepeer-review


Most women with active epilepsy need treatment with antiepileptic drugs during pregnancy. Antiepileptic drugs are also frequently used for other indications, such as migraine, pain syndromes, and psychiatric disorders, which are prevalent among women of childbearing age. Possible teratogenic effects of antiepileptic drugs are therefore of wide concern and the risks imposed by the drugs must be weighed against the risks associated with the disorder being treated. Adverse drug effects on the fetus can present as fetal loss, intrauterine growth retardation, congenital malformations, impaired postnatal development, and behavioural problems. For optimum use of antiepileptic drugs in women of childbearing age and rational management of epilepsy during pregnancy, a thorough understanding of the teratogenic effects of antiepileptic drugs and knowledge of the differences in risks between various treatment options are needed.

Original languageEnglish
Pages (from-to)803-813
Number of pages11
JournalThe Lancet Neurology
Issue number9
Publication statusPublished - Sep 2012

ASJC Scopus subject areas

  • Clinical Neurology


Dive into the research topics of 'Teratogenic effects of antiepileptic drugs'. Together they form a unique fingerprint.

Cite this